Weltweit erster internationaler Patient beginnt im Jiahui International Cancer Center die Behandlung mit einer neu zugelassenen CAR-T-Zelltherapie gegen solide Tumoren

No financial news content was provided—only an HTTP 404/error page message. No company, macro, market, or policy information is available to assess impact or sentiment.

Analysis

No financial news content was provided—only an HTTP 404/error page message. No company, macro, market, or policy information is available to assess impact or sentiment.